eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Middle Ear & Mastoid

Middle Ear Endoscopy

Author: Drew M Horlbeck, MD, Clinical Associate Professor, Department of Otolaryngology, University of Texas Health Science Center; Associate Program Director, Otolaryngology Residency Program, Chairman, Dept of Otolaryngology, Head and Neck Surgery, Wilford Hall Medical Center
Coauthor(s): Matthew Ng, MD, FACS, Assistant Professor, Department of Surgery, Division of Otolaryngology, University of Nevada School of Medicine
Contributor Information and Disclosures

Updated: Dec 21, 2009

History

Mer, in 1967, was the first to describe use of an endoscope to view the anatomy of the middle ear.1 He initially performed endoscopy through a tympanic membrane incision on cadavers and on a feline model. Endoscopy in human patients was only attempted through previously existing perforations. Despite his initial success, the endoscope had only limited use as an instrument to photograph the tympanic membrane.

Two decades would pass before Nomura popularized the idea of a surgical myringotomy in an intact drum to permit endoscopic examination of the middle ear structures.2 Subsequently, direct endoscopy through the middle ear space has been used successfully (1) as an alternate procedure for second-look mastoidectomy, middle ear exploration for perilymphatic fistula, and limited removal of epitympanic cholesteatoma and (2) as an intraoperative aid to visualize the attic, eustachian tube, and sinus tympani.

In 1989, Kimura introduced the concept of endoscopy of the middle ear through the eustachian tube orifice.3 This technique has not met with the same clinical success as transtympanic endoscopy because of the small image size provided by the scope, difficult orientation, and poor illumination. In a recent study, 25% of endoscopy attempts through the eustachian tube orifice were aborted because of local irritation, bleeding, thick mucus, and/or blocked view by bony spicules. Theoretically, when the difficulties of this technique are overcome, it may provide information pertaining to pathologies in the epitympanum, mesotympanum, and mastoid antrum, and it may allow assessment of ossicular chain mobility. For now, however, the authors find only the transtympanic route for middle ear endoscopy to be a clinically viable technique.

Indications

Cholesteatoma

Surgical eradication of cholesteatoma uses canal wall down or canal wall intact techniques. The extent of the disease process dictates the choice of technique. For limited and readily removable disease, the canal wall up technique is frequently employed. Elimination of a mastoid bowl and improved ability for hearing reconstruction are the major advantages of the canal wall up technique. However, the main disadvantage of canal wall up mastoidectomy is the rate of recurrent disease, which may reach 40%. This high rate of persistent cholesteatoma is due to poor visualization of the middle ear regions that harbor residual disease, eg, the attic, eustachian tube, and sinus tympani.4

The sinus tympani is the most frequent site of residual cholesteatoma. Endoscopic intraoperative visualization of these regions has been demonstrated to reduce recurrence of cholesteatoma in canal wall up mastoidectomy. In several series that used an endoscope to complement traditional microscopic techniques, the recurrence rate fell significantly (from 8.6% to 0%).

Second-look procedures

The high rate of residual cholesteatoma in canal wall up mastoidectomies mandates a second-look procedure to ensure freedom from residual disease. This procedure usually involves a standard postauricular approach under a general anesthetic with the same morbidity and a similar recovery period as the original operation.

McKennan was the first to use the endoscope for examining mastoid cavities in patients who had undergone a previous canal wall up procedure. If no residual cholesteatoma existed, the patients did not undergo a standard postauricular approach. Small residual cholesteatoma pearls were removed endoscopically. The discovery of a large cholesteatoma residual requires a standard postauricular approach for removal. McKennan found that patients experienced decreased postoperative morbidity, including a smaller incision, less postoperative swelling, reduced operative time, and reduced auricular numbness. He found a residual cholesteatoma rate of 17%.5

In a 1994 report, Rosenberg and colleagues further evaluated the sensitivity of performing second-look procedures with the endoscope, first using the endoscope to examine pediatric patients undergoing second-look procedures followed by a standard postauricular microscopic procedure.6 The endoscopic findings correlated with findings during the open procedure. Other investigators have confirmed these findings and have concluded that an open second-look procedure might be unnecessary if no cholesteatoma is found during the initial endoscopic procedure.

Deep retraction pockets with attic cholesteatoma

Use of the endoscope has been extended beyond its use as a tool for diagnosing middle ear disease. Middle ear endoscopes have been used, in place of the operative microscope, for management of deep retraction pockets with attic cholesteatoma. The procedure, as described by Tarabichi in 2000, is that of a transcanal atticotomy.7 Patients were carefully observed, on an outpatient basis, to assess for recurrence. Long-term follow up (mean 41 mo) of this procedure demonstrated a 10% recurrence rate. Any disease with extensive mastoid involvement must be handled in traditional fashion.

Ménière disease

Ménière disease is characterized by episodic vertigo, hearing loss, tinnitus, and aural fullness. Episodic vertigo is the most debilitating symptom. Many patients respond well to medical management, including diuretics and salt restriction. Some cases, however, are refractory to treatment and require intervention for control of vertigo.

Various surgical treatments are available to help control vertigo, including labyrinthectomy, endolymphatic shunt procedures, and vestibular neurectomies; however, intratympanic gentamicin injection is an increasingly popular and less invasive alternative. With recent dosing techniques, vertigo control rates can be as high as 90% with hearing loss rates of 3%.

The main diffusion route of gentamicin into the middle ear is through the round window membrane. Studies have demonstrated that the round window membrane may be completely obstructed in 12% of patients and partially obstructed in an additional 17%. Endoscopy performed before instillation of gentamicin can identify the obstruction. Any adhesions near the round window can be removed with variously angled hooks. Performing this maneuver may aid diffusion of gentamicin into the inner ear, thereby assisting treatment effectiveness.

Diagnosis of perilymphatic fistulae

Diagnosis of perilymphatic fistulae remains a challenge. Although the most common presenting symptoms are the triad of tinnitus, vertigo, and hearing loss, these symptoms can occur in a variety of combinations. Presentation can be indistinguishable from that of Ménière disease. A clear antecedent event that results in the symptoms of a fistula is absent in 23-35% of patients, further complicating diagnosis. Additionally, the classic fistulae test is as variable as the presentation, providing positive results in 25-77% of patients. Even with strong clinical suspicion, the odds of finding a definite leak at exploration can be as low as 50%. Even if exploration is undertaken, distinguishing pooling of local anesthesia from true perilymph may be difficult.

Without a clear event or strong clinical history, the decision to surgically explore an ear suspected of harboring a perilymphatic fistula is difficult. This decision is especially confounded by the lack of a sensitive preoperative confirmatory test. As described in the American Journal of Otology, in feline models, Poe surgically created perilymphatic fistulas, which were easily visualized with middle ear endoscopes.8 He followed these experiments with exploration of patients with a high clinical suspicion of perilymphatic fistula, finding no active fistulae, as reported in Laryngoscope. However, Poe placed blood patches transtympanically in 7 patients with strong suspicion. Half of these patients had symptomatic improvement.

Transtympanic middle ear endoscopy is an office-based procedure that can aid diagnosis of perilymphatic fistulae. The transtympanic technique provides excellent visualization of the round window and the oval windows, as can be seen in the image below. Additionally, this technique avoids welling of local anesthetic or fluid within the round and oval window niches. The use of the endoscope to determine the presence of fistulae can obviate the need for a more extensive surgical procedure.

The picture provides a view through the myringoto...

The picture provides a view through the myringotomy site of the round window niche and the stapes suprastructure and footplate.

The picture provides a view through the myringoto...

The picture provides a view through the myringotomy site of the round window niche and the stapes suprastructure and footplate.


Treatment of cerebrospinal fluid otorrhea

Cerebrospinal fluid (CSF) rhinorrhea results from an unwanted connection between the subarachnoid space and the temporal bone. Through this connection, the CSF has a pathway to the unsterile environment of the nasal cavity. The development of this connection may be spontaneous, due to traumatic injuries, or due to surgical complication. The fluid travels through the air cells of the temporal bone to the ear, through the eustachian tube to the nasal cavity. This leaves a patient at risk for meningitis as long as the connection persists. Treatment, which is based the cause, may consist of conservative management or may require surgical intervention. Traditionally, surgery involves a mastoidectomy and packing of the middle ear. Recently, endoscopy to close the eustachian tube has shown promise as an alternative when conservative management fails.9

Surgical Technique

Place the patient in the supine position and clean the external auditory canal of cerumen and debris. Apply topical phenol to the posterior inferior quadrant of the tympanic membrane. Then, inject the posterior canal skin with 1% lidocaine with 1:100,000 epinephrine. The authors do not routinely perform the canal injection when looking for perilymphatic fistulae.

Make a radial 2-mm myringotomy incision along the line of the previously anesthetized drum, as seen in the first image below. Direct the endoscopes into the middle ear and through the myringotomy site by watching the video monitor. The authors then use 1.2-mm diameter 0° and 30° endoscopes. The round window, oval window, and stapes suprastructure are easily visualized, as seen in the second image below. In cases of suspected perilymphatic fistulae, ask the patient to perform the Valsalva maneuver during direct visualization of the fissula ante fenestram and the round window region.

The picture shows a phenolized tympanic membrane ...

The picture shows a phenolized tympanic membrane with a myringotomy in the posterior inferior quadrant.

The picture shows a phenolized tympanic membrane ...

The picture shows a phenolized tympanic membrane with a myringotomy in the posterior inferior quadrant.


The picture provides a view through the myringoto...

The picture provides a view through the myringotomy site of the round window niche and the stapes suprastructure and footplate.

The picture provides a view through the myringoto...

The picture provides a view through the myringotomy site of the round window niche and the stapes suprastructure and footplate.


After endoscopy, place a Teflon patch on the myringotomy incision site. Remove this patch in 2 weeks.

Use McKennan's method to examine mastoid cavities for residual cholesteatoma in second-look procedures. Perform this procedure while the patient is under a general anesthetic in the operating room. Make a 1-cm stab incision in the postauricular region. Next, place an aural speculum in the incision. If bony regrowth is present, use a drill to provide an opening in the mastoid cortex, thus allowing passage of the endoscope. Use the 30° and 0° endoscopes to view the mastoid cavity. If any cholesteatoma is found, the authors convert the operation to an open procedure.

Complications

Potential complications of this procedure include excessive heat and discomfort from the light source. In addition, a risk to the ossicular chain and tympanic membrane exists. The authors have encountered no complications with use of these techniques.

Conclusion

Middle ear endoscopy is a minimally invasive office-based procedure that has demonstrated an important adjunctive role in the management of otologic disease. Middle ear endoscopy has the potential to decrease both patient morbidity and cost without compromising results. Operatively, the use of middle ear endoscopy can complement traditional microscopic mastoid surgery to prevent recurrence and further surgery.

Multimedia

The picture shows a phenolized tympanic membrane ...Media file 1: The picture shows a phenolized tympanic membrane with a myringotomy in the posterior inferior quadrant.
The picture shows a phenolized tympanic membrane ...

The picture shows a phenolized tympanic membrane with a myringotomy in the posterior inferior quadrant.

The picture provides a view through the myringoto...Media file 2: The picture provides a view through the myringotomy site of the round window niche and the stapes suprastructure and footplate.
The picture provides a view through the myringoto...

The picture provides a view through the myringotomy site of the round window niche and the stapes suprastructure and footplate.

Keywords

middle ear, endoscopy, middle ear endoscopy, otology, endoscopy in otology, videoendoscopy of the middle ear, endoscope, endoscopic examination

 


More on Middle Ear Endoscopy

References

References

  1. Mer SB, Derbyshire AJ, Brushenko A, Pontarelli DA. Fiberoptic endotoscopes for examining the middle ear. Arch Otolaryngol. Apr 1967;85(4):387-93. [Medline].

  2. Nomura Y. Effective photography in otolaryngology-head and neck surgery: endoscopic photography of the middle ear. Otolaryngol Head Neck Surg. Jul-Aug 1982;90(4):395-8. [Medline].

  3. Kimura H, Yamaguchi H, Cheng SS, et al. [Direct observation of the tympanic cavity by the superfine fiberscope]. Nippon Jibiinkoka Gakkai Kaiho. Feb 1989;92(2):233-8. [Medline].

  4. Marchioni D, Alicandri-Ciufelli M, Grammatica A, Mattioli F, Presutti L. Pyramidal eminence and subpyramidal space: An endoscopic anatomical study. Laryngoscope. Dec 9 2009;[Medline].

  5. McKennan KX. Endoscopic 'second look' mastoidoscopy to rule out residual epitympanic/mastoid cholesteatoma. Laryngoscope. Jul 1993;103(7):810-4. [Medline].

  6. Rosenberg SI, Silverstein H, Willcox TO, Gordon MA. Endoscopy in otology and neurotology. Am J Otol. Mar 1994;15(2):168-72. [Medline].

  7. Tarabichi M. Endoscopic management of cholesteatoma: long-term results. Otolaryngol Head Neck Surg. Jun 2000;122(6):874-81. [Medline].

  8. Poe DS, Rebeiz EE, Pankratov MM. Evaluation of perilymphatic fistulas by middle ear endoscopy. Am J Otol. Nov 1992;13(6):529-33. [Medline].

  9. Orlandi RR, Shelton C. Endoscopic closure of the eustachian tube. Am J Rhinol. Nov-Dec 2004;18(6):363-5. [Medline].

  10. Badr-el-Dine M. Value of ear endoscopy in cholesteatoma surgery. Otol Neurotol. Sep 2002;23(5):631-5. [Medline].

  11. Edelstein DR, Magnan J, Parisier SC, et al. Microfiberoptic evaluation of the middle ear cavity. Am J Otol. Jan 1994;15(1):50-5. [Medline].

  12. El-Meselaty K, Badr-El-Dine M, Mandour M, et al. Endoscope affects decision making in cholesteatoma surgery. Otolaryngol Head Neck Surg. Nov 2003;129(5):490-6. [Medline].

  13. Fitzgerald DC, Getson P, Brasseux CO. Perilymphatic fistula: a Washington, DC, experience. Ann Otol Rhinol Laryngol. Oct 1997;106(10 Pt 1):830-7. [Medline].

  14. Hawke M. Telescopic otoscopy and photography of the tympanic membrane. J Otolaryngol. Feb 1982;11(1):35-9. [Medline].

  15. Karhuketo TS, Puhakka HJ, Laippala PJ. Endoscopy of the middle ear structures. Acta Otolaryngol Suppl. 1997;529:34-9. [Medline].

  16. Klug C, Fabinyi B, Tschabitscher M. Endoscopy of the middle ear through the eustachian tube: anatomic possibilities and limitations. Am J Otol. May 1999;20(3):299-303. [Medline].

  17. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol. Mar 1999;20(2):209-19. [Medline].

  18. Podoshin L, Fradis M, Ben-David J, et al. Perilymphatic fistula--the value of diagnostic tests. J Laryngol Otol. Jul 1994;108(7):560-3. [Medline].

  19. Poe DS, Rebeiz EE, Pankratov MM, Shapshay SM. Transtympanic endoscopy of the middle ear. Laryngoscope. Sep 1992;102(9):993-6. [Medline].

  20. Rizer FM, House JW. Perilymph fistulas: the House Ear Clinic experience. Otolaryngol Head Neck Surg. Feb 1991;104(2):239-43. [Medline].

  21. Seltzer S, McCabe BF. Perilymph fistula: the Iowa experience. Laryngoscope. Jan 1986;96(1):37-49. [Medline].

  22. Shelton C, Sheehy JL. Tympanoplasty: review of 400 staged cases. Laryngoscope. Jul 1990;100(7):679-81. [Medline].

  23. Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg. May 1999;120(5):649-55. [Medline].

  24. Tarabichi M. Endoscopic management of acquired cholesteatoma. Am J Otol. Sep 1997;18(5):544-9. [Medline].

  25. Thomassin JM, Korchia D, Doris JM. Endoscopic-guided otosurgery in the prevention of residual cholesteatomas. Laryngoscope. Aug 1993;103(8):939-43. [Medline].

  26. Wilson DF, Hodgson RS. Lidocaine in the middle ear. Laryngoscope. Oct 1990;100(10 Pt 1):1059-61. [Medline].

  27. Youssef TF, Poe DS. Endoscope-assisted second-stage tympanomastoidectomy. Laryngoscope. Oct 1997;107(10):1341-4. [Medline].

Further Reading

Keywords

middle ear, endoscopy, middle ear endoscopy, otology, endoscopy in otology, videoendoscopy of the middle ear, endoscope, endoscopic examination

Contributor Information and Disclosures

Author

Drew M Horlbeck, MD, Clinical Associate Professor, Department of Otolaryngology, University of Texas Health Science Center; Associate Program Director, Otolaryngology Residency Program, Chairman, Dept of Otolaryngology, Head and Neck Surgery, Wilford Hall Medical Center
Drew M Horlbeck, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery and North American Skull Base Society
Disclosure: Nothing to disclose.

Coauthor(s)

Matthew Ng, MD, FACS, Assistant Professor, Department of Surgery, Division of Otolaryngology, University of Nevada School of Medicine
Matthew Ng, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Laryngological Rhinological and Otological Society, and Association for Research in Otolaryngology
Disclosure: Nothing to disclose.

Medical Editor

Carol A Bauer, MD, FACS, Associate Professor of Surgery, Division of Otolaryngology-Head and Neck Surgery, Southern Illinois University School of Medicine
Carol A Bauer, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Neurological Association, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Peter S Roland, MD, Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development
Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Alcon labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear corp Honoraria Board membership; Med El corp travel grants Consulting

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.